| 26 Aug, 07:01 pm | — | … | Senores Pharmaceuticals Ltd - 544319 - Announcement under Regulation 30 (LODR)-Change in Management | bse |
| 26 Aug, 06:57 pm | — | … | Senores Pharmaceuticals Ltd - 544319 - Announcement under Regulation 30 (LODR)-Acquisition | bse |
| 26 Aug, 06:56 pm | — | … | Senores Pharmaceuticals Ltd - 544319 - Announcement under Regulation 30 (LODR)-Acquisition | bse |
| 26 Aug, 06:50 pm | — | … | Senores Pharmaceuticals Limited has informed the Exchange regarding Appointment of Mr Viranchi Arvindbhai Shah as Non- Executive Independent Director of the company w.e.f. August 26, 2026. | nse |
| 26 Aug, 06:50 pm | — | … | Approval of Senores Pharmaceuticals Employee Stock Option Scheme 2026 ( ESOS 2026 / SCHEME ) | nse |
| 26 Aug, 06:50 pm | — | … | Proposed incorporation of a Wholly Owned Subsidiary (WOS) in Mexico | nse |
| 26 Aug, 06:50 pm | — | … | Proposed incorporation of a Subsidiary Company in Canada | nse |
| 26 Aug, 06:50 pm | — | … | Senores Pharmaceuticals Limited has informed the Exchange regarding Outcome of Board Meeting held on August 26, 2026. | nse |
| 26 Aug, 06:50 pm | — | … | Senores Pharmaceuticals Limited has informed the Exchange regarding ' Authority to determine materiality of an event or information and disclosure to Stock Exchanges'. | nse |
| 26 Aug, 06:50 pm | — | … | Senores Pharmaceuticals Limited has informed the Exchange regarding Appointment of Mrs Shilpa Sharma as Company Secretary & Compliance Officer of the company w.e.f. August 26, 2026. | nse |
| 24 Aug, 05:46 pm | — | … | Senores Pharmaceuticals Limited has informed the Exchange regarding giving corporate guarantee for credit facilities availed by Apnar Pharma Private Limited, Subsidiary of the Company from ICICI Bank Limited | nse |
| 12 Aug, 04:10 pm | — | … | Senores Pharmaceuticals Ltd - 544319 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 | bse |
| 12 Aug, 04:07 pm | — | … | Senores Pharmaceuticals Ltd - 544319 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 | bse |
| 03 Aug, 03:23 pm | — | … | Senores Pharmaceuticals Limited has informed the Exchange regarding Transcript of Earnings Conference Call held on Monday, July 27, 2026 for Q1FY27. | nse |
| 03 Aug, 03:18 pm | — | … | Senores Pharmaceuticals Ltd - 544319 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript | bse |
| 28 Jul, 10:38 am | — | … | Senores Pharmaceuticals Limited has informed the Exchange regarding Newspaper Publication Extracts of Unaudited Financial Results of the Company for quarter ended June 30, 2026 | nse |
| 27 Jul, 07:26 pm | — | … | Senores Pharmaceuticals Ltd - 544319 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | bse |
| 27 Jul, 07:20 pm | — | … | Senores Pharmaceuticals Limited has informed the Exchange regarding Audio recording of Earnings Conference Call for the quarter ended June 30, 2026 | nse |
| 27 Jul, 05:53 pm | — | … | Senores Pharmaceuticals Ltd - 544319 - Submission Of Statement Of Deviation Or Variation In Utilisation Of Funds Raised Through Preferential Issue Of Convertible Equity Warrants, For The Quarter Ended On June 30, 2026 | bse |
| 27 Jul, 05:49 pm | — | … | Senores Pharmaceuticals Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32 | nse |
| 27 Jul, 05:40 pm | — | … | Senores Pharmaceuticals Ltd - 544319 - Submission Of Statement Of Deviation Or Variation In Utilisation Of Funds Of Public Issue For Quarter Ended On June 30, 2026 | bse |
| 27 Jul, 05:40 pm | — | … | Senores Pharmaceuticals Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32 | nse |
| 27 Jul, 05:32 pm | — | … | Senores Pharmaceuticals Ltd - 544319 - Announcement under Regulation 30 (LODR)-Monitoring Agency Report | bse |
| 27 Jul, 05:28 pm | — | … | Senores Pharmaceuticals Limited has informed Exchange regarding Monitoring Agency Report for quarter ended June 30, 2026 | nse |
| 27 Jul, 03:55 pm | — | … | Senores Pharmaceuticals Ltd - 544319 - Announcement under Regulation 30 (LODR)-Investor Presentation | bse |
| 27 Jul, 03:52 pm | — | … | Senores Pharmaceuticals Limited has informed the Exchange about Investor Presentation | nse |
| 27 Jul, 03:47 pm | — | … | Senores Pharmaceuticals Ltd - 544319 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 27 Jul, 03:44 pm | — | … | Senores Pharmaceuticals Limited has informed the Exchange regarding a Media Release dated July 27, 2026 | nse |
| 27 Jul, 03:39 pm | — | … | Senores Pharmaceuticals Ltd - 544319 - Announcement under Regulation 30 (LODR)-Change in Management | bse |
| 27 Jul, 03:35 pm | — | … | Senores Pharmaceuticals Limited has informed the Exchange regarding Appointment of Ms Anjali Shah as Assistant Vice President- Finance categorized as SMP of the company w.e.f. July 27, 2026 | nse |
| 27 Jul, 03:31 pm | — | … | Senores Pharmaceuticals Ltd - 544319 - Financial Results For Quarter Ended June 30, 2026 | bse |
| 27 Jul, 03:17 pm | — | … | Senores Pharmaceuticals Limited has informed the Exchange regarding Outcome of Board Meeting held on July 27, 2026. | nse |
| 27 Jul, 03:16 pm | — | … | Senores Pharmaceuticals Limited has submitted to the Exchange outcome of Board Meeting dated July 27, 2026 | nse |
| 21 Jul, 04:19 pm | — | … | Senores Pharmaceuticals Limited has informed the Exchange regarding Earnings Conference Call for Q1FY27 scheduled to be held on July 27, 2026 at 05:15 P.M. (IST) | nse |
| 21 Jul, 03:58 pm | — | … | Senores Pharmaceuticals Ltd - 544319 - Board Meeting Intimation for Considering And Approving The Unaudited Consolidated And Standalone Financial Results Of The Company For The Quarter Ended June 30, 2026 And To Transact Other Business Matters | bse |
| 07 Jul, 06:57 pm | — | … | Senores Pharmaceuticals Ltd - 544319 - Submission Of Reconciliation Of Share Capital Audit Report For The Quarter Ended June 30, 2026 | bse |
| 29 Jun, 07:46 pm | — | … | Senores Pharmaceuticals Limited has informed the Exchange regarding Outcome of Board Meeting held on June 29, 2026. | nse |
| 10 Jun, 07:17 pm | procedural | 0 | Senores Pharmaceuticals Limited informed the exchange of an update under Regulation 30(5) of SEBI (LODR) Regulations, 2015. | nse |
| 10 Jun, 07:16 pm | kmp_change | 3 | Senores Pharmaceuticals Limited informed stock exchanges of cessation of Company Secretary and Compliance Officer effective June 10, 2026. | nse |
| 21 May, 05:19 pm | — | … | Senores Pharmaceuticals Ltd - 544319 - Compliances-Reg.24(A)-Annual Secretarial Compliance | bse |
| 19 May, 05:09 pm | — | … | Senores Pharmaceuticals Limited has informed the Exchange regarding Transcript of Earnings Conference Call held on Thursday, May 14, 2026 for Q4FY26 | nse |
| 19 May, 05:07 pm | — | … | Senores Pharmaceuticals Ltd - 544319 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript | bse |
| 15 May, 11:15 am | — | … | Senores Pharmaceuticals Limited has informed the Exchange regarding copy of Newspaper Publication for Audited Consolidated and Standalone financial results for quarter and financial year ended March 31, 2026 | nse |
| 14 May, 07:27 pm | — | … | Senores Pharmaceuticals Ltd - 544319 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | bse |
| 14 May, 07:22 pm | — | … | Senores Pharmaceuticals Limited has informed the Exchange regarding audio recordings of Earnings Conference Call for the quarter and financial year ended March 31, 2026. | nse |
| 14 May, 07:19 pm | — | … | Senores Pharmaceuticals Ltd - 544319 - Submission Of Statement Of Deviation Or Variation In Utilisation Of Funds Raised Through Preferential Issue Of Convertible Equity Warrants, For The Quarter Ended On March 31, 2026 | bse |
| 14 May, 07:15 pm | — | … | Senores Pharmaceuticals Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32 | nse |
| 14 May, 05:10 pm | — | … | Senores Pharmaceuticals Ltd - 544319 - Announcement under Regulation 30 (LODR)-Press Release / Media Release (Revised) | bse |
| 14 May, 05:06 pm | — | … | Senores Pharmaceuticals Limited has informed the Exchange regarding a Corrigendum to the Media Release submitted with the Outcome of the Board Meeting dated May14, 2026 | nse |
| 14 May, 04:58 pm | — | … | Senores Pharmaceuticals Ltd - 544319 - Announcement under Regulation 30 (LODR)-Investor Presentation | bse |